Leap Therapeutics Inc [NASDAQ: LPTX] traded at a high on 2025-07-03, posting a 1.18 gain after which it closed the day’ session at $0.29.
The results of the trading session contributed to over 292332 shares changing hands. Over the past one week, the price volatility of Leap Therapeutics Inc stands at 13.20% while the volatility over the past one month is 12.39%.
The market cap for LPTX stock reached $12.07 million, with 41.44 million shares outstanding and 30.74 million shares in the current float. Compared to the average trading volume of 1.31M shares, LPTX reached a trading volume of 292332 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Leap Therapeutics Inc [LPTX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for LPTX shares is $5.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on LPTX stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Robert W. Baird have made an estimate for Leap Therapeutics Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 29, 2025. The new note on the price target was released on January 29, 2025, representing the official price target for Leap Therapeutics Inc stock. Previously, the target price had yet another raise to $8, while Rodman & Renshaw analysts kept a Buy rating on LPTX stock.
The Price to Book ratio for the last quarter was 0.58, with the Price to Cash per share for the same quarter was set at 0.79.
How has LPTX stock performed recently?
Leap Therapeutics Inc [LPTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.18. With this latest performance, LPTX shares dropped by -21.35% in over the last four-week period, additionally sinking by -90.02% over the last 6 months – not to mention a drop of -89.86% in the past year of trading.
Leap Therapeutics Inc [LPTX]: Deeper insight into the fundamentals
Return on Equity for this stock declined to -149.01%, with Return on Assets sitting at -149.01%.
Earnings analysis for Leap Therapeutics Inc [LPTX]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for LPTX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Leap Therapeutics Inc go to 32.77%.
Insider trade positions for Leap Therapeutics Inc [LPTX]
There are presently around $29.17%, or 34.81% of LPTX stock, in the hands of institutional investors. The top three institutional holders of LPTX stocks are: BALYASNY ASSET MANAGEMENT L.P. with ownership of 3.1 million shares, which is approximately 7.9238%. SAMSARA BIOCAPITAL, LLC, holding 2.44 million shares of the stock with an approximate value of $$4.79 million in LPTX stocks shares; and SAMSARA BIOCAPITAL, LLC, currently with $$2.55 million in LPTX stock with ownership which is approximately 3.3229%.
